Last update: April 17, 2016
Minimal risk for breastfeeding and infant.
Stimulant of the intestine and laxative drug through irritation of mucosa which is similar to bisacodyl.
Its low oral bioavailability with minimal intestinal absorption causes plasma levels to be very low, that explains the observed failure of excretion into breast milk (undetectable levels).
Authorized for use in infants from age one month old.
To prevent or treat constipation is essential to have a balanced and fiber-rich diet, with a lot of fluids and exercise.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.